Newly discovered role of AF1q in neuroblastoma
Researchers have identified that AF1q is highly expressed in neuroblastoma, and could be used to destabilise N-Myc.
List view / Grid view
Researchers have identified that AF1q is highly expressed in neuroblastoma, and could be used to destabilise N-Myc.
Researchers have gained a better understanding of the genes and biological processes that could influence POAG pathogenesis.
Researchers have discovered the role of two genes that protect mammalian germ cells, which could influence male fertility.
Distinct macrophage signatures that align specifically with regeneration could offer novel therapies to enhance wound healing.
A deep learning model developed using circulating cell-free DNA outperformed traditional screening methods for gestational diabetes mellitus.
A new project plans to elucidate the relationship between the glucosylceramidase beta gene and Parkinson’s disease.
PLK4 inhibition could be a novel therapeutic for an acute myeloid leukaemia subtype carrying the TP53 mutation.
The ML algorithm explores how genetic mutations collectively influence a tumour’s reaction to drugs impeding DNA replication.
A potential link between truncating variants and the development of DCM has been found, and a patient-focused registry about PPCM was made.
Genetic factors that promote disease development accumulated in CD4+ T cells exhibiting specific gene programmes.
Disruptions in TP53 and RB1 are key influencers that cause changes in the risk of mutations across chromosomes.
Researchers found that ANG in its mutated form slows stem cell differentiation, resulting in neurodevelopmental defects in adult nerve cells.
Using shRNA screening enabled researchers to investigate the roles of individual specific factors in maintaining the network found in AML.
Using phosphoproteomics, the calcium channel Cav2.3 was found as a target to treat a type of genetic epilepsy, CDKL5 deficiency disorder.
Using saturation genome editing, researchers have created a map of disease-causing mutations for neurodevelopmental disorders and cancer.